Back to today’s briefing

Story perspectives

Serum Institute Unveils Malaria Vaccine Amid Funding Concerns

1/23/2025

43 6

Summary

Story summary

Adar Poonawalla, CEO of the Serum Institute of India, unveiled ambitious plans for new vaccines targeting malaria and other mosquito-borne diseases at the World Economic Forum. With a malaria vaccine already showing 77% efficacy in Africa at just $4, the announcement comes amid rising concerns over U.S. funding cuts to the WHO, threatening vital global health efforts.

1 of 1

Story summary

Adar Poonawalla, CEO of the Serum Institute of India, unveiled ambitious plans for new vaccines targeting malaria and other mosquito-borne diseases at the World Economic Forum. With a malaria vaccine already showing 77% efficacy in Africa at just $4, the announcement comes amid rising concerns over U.S. funding cuts to the WHO, threatening vital global health efforts.